HomeCompareTOPPX vs JNJ

TOPPX vs JNJ: Dividend Comparison 2026

TOPPX yields 7.82% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOPPX wins by $13.5K in total portfolio value
10 years
TOPPX
TOPPX
● Live price
7.82%
Share price
$25.59
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.6K
Annual income
$1,282.27
Full TOPPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TOPPX vs JNJ

📍 TOPPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOPPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOPPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOPPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOPPX
Annual income on $10K today (after 15% tax)
$664.40/yr
After 10yr DRIP, annual income (after tax)
$1,089.93/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TOPPX beats the other by $386.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOPPX + JNJ for your $10,000?

TOPPX: 50%JNJ: 50%
100% JNJ50/50100% TOPPX
Portfolio after 10yr
$26.8K
Annual income
$1,055.02/yr
Blended yield
3.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TOPPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOPPX buys
0
JNJ buys
0
No recent congressional trades found for TOPPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOPPXJNJ
Forward yield7.82%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.6K$20.0K
Annual income after 10y$1,282.27$827.78
Total dividends collected$10.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TOPPX vs JNJ ($10,000, DRIP)

YearTOPPX PortfolioTOPPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,482$781.65$10,676$355.77+$806.00TOPPX
2$13,124$838.75$11,407$389.39+$1.7KTOPPX
3$14,939$896.01$12,198$426.53+$2.7KTOPPX
4$16,938$953.18$13,056$467.62+$3.9KTOPPX
5$19,133$1,010.02$13,987$513.12+$5.1KTOPPX
6$21,539$1,066.31$14,998$563.56+$6.5KTOPPX
7$24,169$1,121.85$16,098$619.52+$8.1KTOPPX
8$27,037$1,176.46$17,295$681.69+$9.7KTOPPX
9$30,159$1,229.98$18,599$750.82+$11.6KTOPPX
10$33,553$1,282.27$20,022$827.78+$13.5KTOPPX

TOPPX vs JNJ: Complete Analysis 2026

TOPPXStock

The fund invests primarily in the common stocks of small and mid cap companies which have the potential to deliver above-average long-term earnings growth. The adviser defines small cap companies with a market capitalization of less than $3 billion and mid cap companies as companies with a market capitalization greater than $3 billion but less than the largest stock by market capitalization in the Russell Midcap® Index. In addition, the fund may invest in large cap companies. Market capitalization is measured at the time of initial purchase.

Full TOPPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TOPPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOPPX vs SCHDTOPPX vs JEPITOPPX vs OTOPPX vs KOTOPPX vs MAINTOPPX vs ABBVTOPPX vs MRKTOPPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.